GO:0000118 histone deacetylase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000118 histone deacetylase complex is a cellular component defined as a protein complex that possesses histone deacetylase activity.
• Major complexes include Sin3, NuRD, CoREST, SMRT/N-CoR, MiDAC, and Rpd3S, each with distinct subunit composition and targeting mechanisms [1,2,4,6,8].
• Histone deacetylase complexes remove acetyl groups from lysine residues on histone tails, leading to chromatin compaction and transcriptional repression.
• They regulate essential processes such as development, differentiation, stress responses, and neuronal outgrowth [5,8].
• Dysregulation of histone deacetylase complexes is implicated in cancer, neurodevelopmental disorders, and neurodegeneration [4,8].
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect subunit-specific functions and therapeutic potential [4,8].
Description
The histone deacetylase complex (GO:0000118) is a cellular component defined by its possession of histone deacetylase activity, which removes acetyl groups from lysine residues on histone proteins. This enzymatic activity is fundamental to chromatin remodeling and transcriptional regulation, as deacetylation promotes a compact, repressive chromatin state. These complexes are not monolithic; they comprise multiple subunits that confer substrate specificity, targeting to genomic loci, and responsiveness to signaling pathways [1,2,4]. Understanding the structure, composition, and regulation of histone deacetylase complexes is critical for deciphering epigenetic mechanisms in development, disease, and cellular stress responses [5,8]. The importance of these complexes extends beyond basic biology; they are validated drug targets in oncology and neurology, and their subunit-specific functions are being unraveled using advanced genetic and biochemical tools [4,8].
histone deacetylase complex At A Glance
| GO ID | GO:0000118 |
|---|---|
| GO term | histone deacetylase complex |
| Ontology | cellular_component |
| Synonym | HDAC complex |
| Major function | Removal of acetyl groups from histone lysines, leading to transcriptional repression |
| Subunit composition | Varies; includes catalytic HDAC subunits (e.g., HDAC1/2/3) and auxiliary proteins (e.g., Sin3, CoREST, MiDAC subunits) |
| Associated processes | Chromatin remodeling, transcriptional regulation, development, stress response |
| Disease relevance | Cancer, neurodevelopmental disorders, neurodegeneration |
What Is GO:0000118?
According to the Gene Ontology, GO:0000118 (histone deacetylase complex) is a protein complex that possesses histone deacetylase activity. This means the complex as a whole can catalyze the removal of acetyl groups from histone proteins, typically on lysine residues, thereby modulating chromatin structure and gene expression.
Why Is histone deacetylase complex Important in Cell Biology?
Histone deacetylase complexes are central to epigenetic regulation, controlling gene expression programs that govern cell fate, proliferation, and stress responses [4,5]. Their dysfunction is linked to a wide range of human diseases, including cancers, where aberrant deacetylation silences tumor suppressors, and neurodevelopmental disorders, where mutations in subunits impair neuronal development [4,8]. Moreover, these complexes are targets of clinically approved inhibitors (e.g., vorinostat, romidepsin) for treating cutaneous T-cell lymphoma, underscoring their therapeutic relevance. Research into their structure and regulation continues to reveal opportunities for more selective pharmacological interventions [2,4].
• Regulate chromatin structure and gene expression by deacetylating histone lysines.
• Control developmental processes, including neurogenesis and neurite outgrowth.
• Mediate stress responses in plants and other organisms.
• Implicated in cancer pathogenesis through silencing of tumor suppressor genes.
• Associated with neurodevelopmental disorders such as intellectual disability.
• Serve as targets for FDA-approved HDAC inhibitors in oncology.
• Involved in nuclear hormone receptor signaling via HDAC3 complex.
• Modulated by post-translational modifications like sumoylation.
• Exhibit structural diversity that determines substrate specificity [2,6].
• Offer potential for CRISPR-based functional studies and therapeutic targeting [4,8].
Core Biology of the histone deacetylase complex
What Happens During histone deacetylase complex?
In simple terms: The complex removes acetyl tags from histones, causing DNA to wrap tighter and genes to be turned off.
Histone deacetylase complexes catalyze the hydrolysis of acetyl groups from acetyl-lysine residues on histone tails, reversing the action of histone acetyltransferases. This deacetylation increases the positive charge of histones, strengthening their interaction with negatively charged DNA and promoting chromatin compaction. Consequently, transcription factors and RNA polymerase have reduced access to gene promoters, leading to transcriptional repression. The process is dynamic and reversible, allowing cells to rapidly alter gene expression in response to developmental or environmental cues.
Structure and Composition of histone deacetylase complex
In simple terms: These complexes are molecular machines made of a catalytic engine and several helper proteins that decide where and when to act.
Histone deacetylase complexes are multi-subunit assemblies. The catalytic core typically consists of class I HDACs (HDAC1, HDAC2, HDAC3) or class II HDACs, which require association with cofactors for activity [2,4]. For example, the Sin3 complex contains HDAC1/2, Sin3A/B, RbAp46/48, and SAP30, while the NuRD complex includes HDAC1/2, MTA1/2/3, MBD3, and RbAp46/48. The CoREST complex comprises HDAC1/2, CoREST, and LSD1. The SMRT/N-CoR complex includes HDAC3 and TBL1/TBLR1. The MiDAC complex contains HDAC1/2, MIDEAS, and other subunits. Structural studies have revealed how subunits like Rpd3S in yeast engage nucleosomes to achieve specific deacetylation patterns.
Molecular Mechanism of histone deacetylase complex
In simple terms: The catalytic subunit uses a zinc ion to cleave acetyl groups, and other subunits guide it to the right genes.
The catalytic mechanism of histone deacetylases relies on a conserved active site containing a zinc ion that activates a water molecule for nucleophilic attack on the acetyl-lysine bond. This reaction releases acetate and regenerates the unmodified lysine. The activity is tightly regulated by associated subunits that mediate targeting to specific chromatin regions through interactions with DNA-binding proteins, histone modifications, or non-coding RNAs [1,4]. For instance, the HDAC3 complex is recruited to nuclear hormone receptors and requires inositol tetraphosphate as a cofactor. Additionally, post-translational modifications such as sumoylation can modulate complex assembly and function.
Regulation of histone deacetylase complex activity
In simple terms: Cells control these complexes by adding chemical tags to their subunits, changing their partners, or responding to signals.
Histone deacetylase complexes are regulated at multiple levels. Subunit phosphorylation, sumoylation, and ubiquitination can alter complex stability, localization, or enzymatic activity. For example, sumoylation of histones promotes Set3 histone-deacetylase complex-mediated transcriptional regulation in yeast. In Arabidopsis, Histone Deacetylase Complex 1 (HDC1) interacts with histone H1 to moderate stress responsiveness. In mammals, the MIER1 histone deacetylase complex exhibits histone-chaperone activity, suggesting additional regulatory roles beyond deacetylation. Signaling pathways, such as nuclear hormone receptor signaling, directly recruit HDAC3 complexes to target genes.
Key Genes Involved in GO:0000118 histone deacetylase complex
The following genes encode subunits of histone deacetylase complexes and are commonly studied to understand complex assembly, targeting, and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HDAC1 | Catalytic subunit of Sin3, NuRD, CoREST complexes | Knockout leads to embryonic lethality; studied in cancer and development |
| HDAC2 | Catalytic subunit, often redundant with HDAC1 | Implicated in neuronal function and cancer; target of inhibitors |
| HDAC3 | Catalytic subunit of SMRT/N-CoR complex | Regulates nuclear hormone receptor signaling; requires inositol tetraphosphate |
| SIN3A | Scaffold protein in Sin3 complex | Essential for transcriptional repression; mutations linked to neurodevelopmental disorders |
| SIN3B | Paralog of SIN3A | Modulates complex stability and targeting |
| MTA1 | Subunit of NuRD complex | Associated with cancer metastasis and chromatin remodeling |
| MTA2 | Subunit of NuRD complex | Involved in gene silencing and DNA repair |
| MBD3 | Methyl-CpG-binding domain protein in NuRD | Targets complex to methylated DNA |
| CoREST | Subunit of CoREST complex | Links HDAC1/2 to LSD1 for coordinated repression |
| LSD1 | Histone demethylase in CoREST complex | Integrates deacetylation and demethylation |
| TBL1 | Subunit of SMRT/N-CoR complex | Mediates recruitment to nuclear receptors |
| TBLR1 | Paralog of TBL1 | Involved in HDAC3 complex assembly |
| MIER1 | Subunit of MIER1 HDAC complex | Exhibits histone-chaperone activity |
| MIDEAS | Subunit of MiDAC complex | Regulates neurodevelopmental gene expression |
| Rpd3 | Yeast homolog of HDAC1/2 | Model for studying Rpd3S complex structure |
| Set3 | Yeast HDAC complex subunit | Regulated by histone sumoylation |
| HDC1 | Plant-specific HDAC complex subunit | Moderates stress responses in Arabidopsis |
How Is histone deacetylase complex Regulated?
Histone deacetylase complex activity is regulated by post-translational modifications of subunits, such as sumoylation, which can promote complex assembly and targeting. In plants, the HDC1 subunit interacts with histone H1 to modulate stress-responsive gene expression. In mammals, the HDAC3 complex requires inositol tetraphosphate as a cofactor and is recruited by nuclear hormone receptors. Additionally, the MIER1 complex possesses histone-chaperone activity, suggesting a broader role in chromatin dynamics.
histone deacetylase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HDAC1 | Cancer (e.g., breast, gastric) | Knockout in cancer cell lines; xenograft models |
| HDAC2 | Neurodevelopmental disorders, cancer | Conditional knockout in neurons; overexpression in cell lines |
| SIN3A | Intellectual disability, developmental delay | Patient-derived iPSCs; knockout mice |
| MIDEAS | Neurodevelopmental disorders | Knockout in neuronal cell lines; zebrafish models |
| MIER1 | Cancer, chromatin regulation | Knockdown in cancer cells; histone chaperone assays |
Histone deacetylase complexes in cancer
Aberrant recruitment of histone deacetylase complexes leads to silencing of tumor suppressor genes, promoting oncogenesis. For example, the NuRD complex is associated with metastasis, and overexpression of HDAC1/2 correlates with poor prognosis in various cancers. HDAC inhibitors like vorinostat are approved for cutaneous T-cell lymphoma, validating these complexes as therapeutic targets.
Neurodevelopmental disorders
Mutations in subunits of histone deacetylase complexes, such as SIN3A and MIDEAS, have been linked to neurodevelopmental disorders characterized by intellectual disability and developmental delay. The MiDAC complex regulates a neurodevelopmental gene expression program essential for neurite outgrowth, and its disruption impairs neuronal differentiation.
Neurodegeneration
Histone deacetylase complexes contribute to neurodegeneration by repressing genes involved in neuronal survival and plasticity. HDAC inhibitors have shown neuroprotective effects in models of Alzheimer's and Parkinson's diseases, although the specific roles of individual complexes remain under investigation.
From histone deacetylase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of HDAC1 in tumor growth? | HDAC1 knockout cancer cell lines and mouse xenografts |
| How does HDAC3 mutation affect nuclear receptor signaling? | Point mutation knock-in of HDAC3 in cell lines |
| Does MIDEAS haploinsufficiency impair neurite outgrowth? | MIDEAS knockout or knockdown in primary neurons |
| Can we tag endogenous HDAC1 for live imaging? | Knock-in of fluorescent tag (e.g., GFP) at HDAC1 locus |
| What is the effect of SIN3A overexpression? | Overexpression of SIN3A in cell lines and transcriptomics |
| How does sumoylation regulate Set3 complex? | Point mutation of sumoylation sites in yeast |
How to Study the histone deacetylase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genomic binding of HDAC subunits and histone acetylation | Mapping complex localization and chromatin state |
| AP-MS | Protein-protein interactions and subunit composition | Identifying novel complex components |
| Cryo-EM | 3D structure of complexes at near-atomic resolution | Understanding nucleosome engagement |
| RNA-seq | Transcriptional changes upon complex perturbation | Identifying target genes and pathways |
| Ribo-seq | Translational efficiency and ribosome occupancy | Assessing effects on protein synthesis |
| CRISPR screens | Gene essentiality and synthetic lethality | Discovering vulnerabilities in cancer cells |
| Histone acetylation assays | Enzymatic activity of HDAC complexes | Measuring deacetylase activity in vitro |
| Live-cell imaging | Dynamic localization of tagged subunits | Tracking complex assembly and movement |
Chromatin immunoprecipitation (ChIP)
ChIP with antibodies against HDAC subunits or acetylated histones identifies genomic binding sites and changes in histone acetylation. Coupled with sequencing (ChIP-seq), it provides genome-wide maps of complex localization and chromatin state.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) reveals subunit composition and dynamic interactions of histone deacetylase complexes [2,4]. Proximity labeling (BioID) can capture transient interactions in living cells.
Structural biology
Cryo-electron microscopy and X-ray crystallography have elucidated the architecture of complexes like Rpd3S bound to nucleosomes, revealing mechanisms of substrate recognition and catalysis. These studies inform drug design targeting specific complexes.
Functional genomics
RNA-seq and ribosome profiling after knockout or knockdown of complex subunits reveal transcriptional and translational changes. CRISPR screens can identify synthetic lethal interactions with HDAC inhibitors.
How CRISPR Can Be Used to Study GO:0000118 histone deacetylase complex
Knockout
CRISPR knockout of catalytic subunits (e.g., HDAC1, HDAC2) or scaffold proteins (e.g., SIN3A) abolishes complex function, enabling studies of loss-of-function phenotypes in development and disease [4,8]. Conditional knockout models can bypass embryonic lethality.
Point Mutation
Introducing point mutations in catalytic residues or regulatory sites (e.g., sumoylation sites) via CRISPR base editing or homology-directed repair allows precise dissection of enzymatic activity versus scaffolding functions [1,3].
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) or fluorescent reporters at endogenous loci facilitates live imaging, ChIP, and proteomics without overexpression artifacts. Knock-in of disease-associated mutations models patient-specific defects.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of complex subunits can reveal gain-of-function effects, such as oncogenic transformation or altered differentiation. Inducible systems provide temporal control.
How EDITGENE Supports histone deacetylase complex Research
Researchers studying histone deacetylase complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic models that can isolate the contribution of individual subunits and their enzymatic activities. EDITGENE provides end-to-end CRISPR solutions to generate such models efficiently and reliably.
Contact EDITGENE today to design your custom CRISPR model for histone deacetylase complex research.
Frequently Asked Questions About histone deacetylase complex
What is the histone deacetylase complex?
The histone deacetylase complex (GO:0000118) is a protein complex that removes acetyl groups from histones, leading to chromatin compaction and transcriptional repression.
What genes are involved in the histone deacetylase complex?
Key genes include HDAC1, HDAC2, HDAC3, SIN3A, MTA1, MBD3, CoREST, TBL1, MIER1, and MIDEAS, among others [1,2,4,8].
What is the function of GO:0000118?
Its function is to catalyze histone deacetylation, thereby regulating gene expression, development, and stress responses [4,5].
How is the histone deacetylase complex regulated?
It is regulated by post-translational modifications (e.g., sumoylation), cofactor binding (e.g., inositol tetraphosphate), and interaction with nuclear hormone receptors [1,3].
What diseases are associated with histone deacetylase complexes?
They are implicated in cancer, neurodevelopmental disorders, and neurodegeneration [4,8].
What are the major subunits of the NuRD complex?
The NuRD complex contains HDAC1/2, MTA1/2/3, MBD3, and RbAp46/48.
How can CRISPR be used to study histone deacetylase complexes?
CRISPR knockout, knock-in, point mutation, and overexpression models allow precise functional dissection of subunits and their roles in disease [4,8].
What is the role of HDAC3 complex in nuclear hormone receptor action?
The HDAC3 complex is recruited by nuclear hormone receptors to repress target genes, requiring inositol tetraphosphate as a cofactor.
What is the MiDAC complex?
MiDAC is a histone deacetylase complex containing HDAC1/2 and MIDEAS that regulates neurodevelopmental gene expression and neurite outgrowth.
How does sumoylation affect histone deacetylase complexes?
Sumoylation of histones promotes Set3 histone-deacetylase complex-mediated transcriptional regulation in yeast.
Conclusion
The histone deacetylase complex (GO:0000118) is a fundamental epigenetic regulator that controls chromatin structure and gene expression through histone deacetylation. Its diverse subunit compositions enable context-specific functions in development, stress responses, and disease [1,5,8]. Understanding these complexes at molecular and structural levels offers opportunities for targeted therapies, particularly in cancer and neurodevelopmental disorders [2,4]. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate their roles and therapeutic potential [4,8].
References
- 1. Ishii S. 2021. The Role of Histone Deacetylase 3 Complex in Nuclear Hormone Receptor Action.. Int J Mol Sci 22(17) PMID: 34502048
- 2. Wang X et al.. 2023. Class I histone deacetylase complex: Structure and functional correlates.. Proc Natl Acad Sci U S A 120(30):e2307598120 PMID: 37459529
- 3. Ryu HY et al.. 2020. Histone sumoylation promotes Set3 histone-deacetylase complex-mediated transcriptional regulation.. Nucleic Acids Res 48(21):12151-12168 PMID: 33231641
- 4. Asmamaw MD et al.. 2024. Histone deacetylase complexes: Structure, regulation and function.. Biochim Biophys Acta Rev Cancer 1879(5):189150 PMID: 38971208
- 5. Perrella G et al.. 2024. Histone Deacetylase Complex 1 and histone 1 epigenetically moderate stress responsiveness of Arabidopsis thaliana seedlings.. New Phytol 241(1):166-179 PMID: 37565540
- 6. Li W et al.. 2023. Structure of histone deacetylase complex Rpd3S bound to nucleosome.. Nat Struct Mol Biol 30(12):1893-1901 PMID: 37798513
- 7. Wang S et al.. 2023. A potential histone-chaperone activity for the MIER1 histone deacetylase complex.. Nucleic Acids Res 51(12):6006-6019 PMID: 37099381
- 8. Mondal B et al.. 2020. The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth.. Elife 9 PMID: 32297854
